Uncategorized
This Medford Clinic Is Developing a Coronavirus Vaccine, and You Wouldn’t Even Know It
Since July, the institute has been one of the staging grounds for a quest to find a vaccine for the novel coronavirus, which causes a disease that has killed more than 700 people in Oregon, more than 230,000 in the US, and 1.2 million worldwide. And inside, Gregg Lucksinger, the interim medical director of the institute, taps a business card against an oval wooden table in a brightly lit corner room. He leans back in an office chair and reminisces about the lessons learned in Liberia, where he worked in an Ebola treatment unit in 2015. He hopes those lessons will aide him and his colleagues now.
“In [Liberia], the epidemic overwhelmed health systems…. It was really fascinating to see that,” he says. “And that’s what we’re struggling with in the United States to prevent from happening. We’ve been really on the edge in a few places.”
Lucksinger’s work in clinical research began in Austin, Texas, during the HIV epidemic of the 1980s. He went on to help develop vaccines and/or therapeutics for HIV, hepatitis C, and Ebola.
Now, another complicated and highly contagious virus threatens humanity. Lucksinger and the institute in Oregon are working on two Phase 3 COVID-19 vaccine trials. The first, produced by biotech startup Moderna (which has been proven to reduce the risk of COVID-19 infection by 94.5 percent), has wrapped up its enrollment period and moved to data collection, a process by which research coordinators follow up with volunteers to see if they’ve developed symptoms of or contract the coronavirus as they go about their daily lives. This stage could take a year or two. The second trial is for a vaccine produced by Novavax. Under the White House’s Operation Warp Speed (OWS), a $10 billion initiative, COVID-19 vaccine and therapeutic trials have been accelerated, compressing what typically takes years into months. By running various processes in parallel and increasing the number of volunteers from a couple hundred to at least 30,000 for each trial, OWS hopes to have a vaccine by early 2021.
-
Crime & Safety4 days ago
Child was obligated to put on an eIectric coIIar, which was used repeatedly, and keep it on at all times while at home so her parent could use it as discipIine whenever the child’s behavior displeased her; charges
-
Eugene1 week ago
Eugene Police Department welcomes newest graduates to the force
-
Eugene7 days ago
Eugene police detain four after shots fired in Barger area, investigation ongoing
-
Eugene1 week ago
Eugene Springfield firefighters dedicate personal time to advanced training at Chemeketa Fire Conference
-
Oregon5 days ago
ODFW deploys nets in Wallowa Lake to monitor fish population and assess lake trout impact
-
Oregon5 days ago
Oregon Senate Committee discusses Senate Bill 829 to provide financial relief for affordable housing and shelter providers facing insurance rate hikes
-
Eugene7 days ago
Emergency crews rescue trapped driver after crash at Park and Northwest Expressway
-
Eugene2 days ago
65-year-old woman arrested on charges of murder in the second degree after 63-year-old man dies from stab wounds